BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6777814)

  • 1. Behavioral effects of dopamine agonists across the estrous cycle in rats.
    Steiner M; Katz RJ; Carroll BJ
    Psychopharmacology (Berl); 1980; 71(2):147-51. PubMed ID: 6777814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of age on behavioral responses to dopamine agonists in the rat.
    Ushijima I; Mizuki Y; Soeda K; Kishimoto O; Hara T; Yamada M
    Eur J Pharmacol; 1987 Jun; 138(1):101-6. PubMed ID: 2887433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of apomorphine from bromocriptine, piribidel and TRH by chronic administration in rats.
    Porreca F; Cowan A; Tallarida RJ
    Psychopharmacology (Berl); 1982; 76(1):70-4. PubMed ID: 6805012
    [No Abstract]   [Full Text] [Related]  

  • 4. Behavioral evidence for supersensitivity after chronic bromocriptine administration.
    Smith RC; Strong JR; Hicks PB; Samorajski T
    Psychopharmacology (Berl); 1979 Feb; 60(3):241-6. PubMed ID: 108701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the estrous cycle and estradiol on the behavioral effects of amphetamine and apomorphine in rats.
    Díaz-Véliz G; Baeza R; Benavente F; Dussaubat N; Mora S
    Pharmacol Biochem Behav; 1994 Dec; 49(4):819-25. PubMed ID: 7886093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential ability of selective and non-selective dopamine agonists to induce climbing in the rat indicates the involvement of both D-1 and D-2 receptors in this behaviour.
    Davis A; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1990; 100(1):19-26. PubMed ID: 1967499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
    Johnson AM; Loew DM; Vigouret JM
    Br J Pharmacol; 1976 Jan; 56(1):59-68. PubMed ID: 943193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of SR 48692, a selective non-peptide neurotensin receptor antagonist, on two dopamine-dependent behavioural responses in mice and rats.
    Poncelet M; Souilhac J; Gueudet C; Terranova JP; Gully D; Le Fur G; Soubrié P
    Psychopharmacology (Berl); 1994 Oct; 116(2):237-41. PubMed ID: 7862953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detailed analysis of estrous-related changes in wheel running and self-stimulation.
    Steiner M; Katz RJ; Carroll BJ
    Physiol Behav; 1982 Jan; 28(1):201-4. PubMed ID: 7200615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ontogenesis of rearing and stereotypy responses to apomorphine in the rat.
    Nomura Y; Segawa T
    J Pharmacobiodyn; 1980 Feb; 3(2):69-73. PubMed ID: 7193721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An observational method for quantifying the behavioural effects of dopamine agonists: contrasting effects of d-amphetamine and apomorphine.
    Fray PJ; Sahakian BJ; Robbins TW; Koob GF; Iversen SD
    Psychopharmacology (Berl); 1980; 69(3):253-9. PubMed ID: 6774363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of 7-OH-DPAT on the development of behavioral sensitization to apomorphine and cocaine.
    Mattingly BA; Caudill A; Abel M
    Pharmacol Biochem Behav; 2001 Mar; 68(3):417-26. PubMed ID: 11325394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioural effects in the rat of the putative dopamine D3 receptor agonist 7-OH-DPAT: comparison with quinpirole and apomorphine.
    Depoortere R; Perrault G; Sanger DJ
    Psychopharmacology (Berl); 1996 Apr; 124(3):231-40. PubMed ID: 8740044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of three dopamine agonists: apomorphine, bromocriptine and lergotrile.
    Silbergeld EK; Pfeiffer RF
    J Neurochem; 1977 Jun; 28(6):1323-6. PubMed ID: 577501
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhanced stereotypic behavior by chronic treatment with bromocriptine accompanies increase of D-1 receptor binding.
    Le WD; Zhou XD; Jin GZ
    Life Sci; 1988; 42(19):1841-5. PubMed ID: 2966885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individual motor activity--relationships to dopaminergic responses.
    Schumacher HE; Oehler J; Jaehkel M
    Pharmacol Biochem Behav; 1994 Aug; 48(4):839-44. PubMed ID: 7972286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromocriptine enhances the behavioural effects of apomorphine and dopamine after systemic or intracerebral injection in rats.
    Jenkins OF; Jackson DM
    Neuropharmacology; 1986 Nov; 25(11):1243-9. PubMed ID: 3796797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of chronic bromocriptine and L-dopa on spiperone binding and apomorphine-induced stereotypy.
    Globus M; Bannet J; Lerer B; Belmaker RH
    Psychopharmacology (Berl); 1982; 78(1):81-4. PubMed ID: 6815701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of the increase in apomorphine-induced stereotypy and aggression in REM sleep deprived rats by dopamine agonist pretreatments.
    Troncone LR; Ferreira TM; Braz S; Silveira Filho NG; Tufik S
    Psychopharmacology (Berl); 1988; 94(1):79-83. PubMed ID: 3126531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic treatment with bromocriptine induces behavioral supersensitivity in rats.
    Hassan MN; Higgins D; Traub M; Fahn S
    Life Sci; 1986 Aug; 39(6):513-8. PubMed ID: 3090394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.